Valneva

Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly. https://ow.ly/zrOt50WooiC

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus. https://ow.ly/qGvQ50WgbWU

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance. https://ow.ly/xc7u50Wg62b

Given the rise of global temperatures and more frequent extreme weather events, the risk of mosquito-borne diseases is no longer confined to tropical regions - it is increasing in Europe too.🦟   We are pleased to share our new report, ‘Strengthening preparedness against the threat of mosquito-borne diseases in the UK, May 2025’. Developed in partnership with leading healthcare professionals and vector-borne disease experts, the report explores the UK’s current level of preparedness and outlines concrete actions to strengthen resilience.   👉 Read the full report here: https://bit.ly/4lmUnci   #AdvancingVaccinesForBetterLives

We were honoured to welcome CEPI – the CEPI (Coalition for Epidemic Preparedness Innovations) – to Valneva’s headquarters in Vienna for a dedicated mini symposium focused on global health innovation and pandemic preparedness. 🌍 This visit brought together thought leaders, scientists, and public health experts for a day of insightful exchange and collaboration. We were especially pleased to host CEPI’s CEO, Richard Hatchett, who delivered a powerful keynote on strengthening worldwide preparedness through equitable vaccine development, saying: “The COVID-19 pandemic reminded us that pathogens move faster than politics or procurement. To prevent future pandemics, we must move even faster. Austria’s biomedical innovations ecosystem is making notable contributions to global preparedness and Valneva is a key example. Together, with our partners, we can work to efficiently move from scientific discovery to delivery and protect humanity from these pernicious viral threats.”   🧬 The symposium featured a keynote by Dr. Richard Hatchett on global preparedness, a panel discussion on vaccine development for global health, and networking sessions aimed at fostering future partnerships. This event reflects our shared commitment to advancing vaccine science and building resilient systems for future health challenges. Thank you to CEPI and all participants for an inspiring and forward-thinking event. Together, we’re shaping the future of global health. 💡 #AdvancingVaccinesForBetterLives 

Each year, Shigella - a highly contagious bacterial infection - is estimated to cause around 600,000 deaths in children under five, with the greatest impact in low- and middle-income countries. #shigella #AdvancingVaccinesForBetterLives #globalhealth #publichealth 

Valneva was delighted to be asked to take part in the recent Bionow Conference in Newcastle, England. This one-day conference brought together industry, academia, and experts in life sciences from across the UK. Valneva Scotland’s Managing Director Greig Rooney BSc(Hons), CMgr, FCMI Rooney joined an expert panel discussion on developing flexible, sustainable, and scalable labs for the future with a specific focus on its state-of-the-art Almeida manufacturing building in Livingston, Scotland.   #AdvancingVaccinesForBetterLives  

The rapid spread of tiger mosquitos, due to climate change, poses a notable public health threat in Europe. A recent study published in The Lancet Planetary Health highlights that due to the mosquitos’ ability to transmit diseases, such as dengue and chikungunya - which were once limited to the tropics - half of the world is now at risk of contracting these illnesses. The immense public health threat of infectious diseases is undeniable and exacerbated by climate change, emphasizing the serious need for proactive disease intervention. At Valneva we are working tirelessly to develop potential solutions to help protect against these kinds of threats. To learn more, read the study here: https://ow.ly/AOmH50W7NUh #travelhealth #infectiousdiseases #mosquitobornediseases #AdvancingVaccinesForBetterLives

The rapid spread of tiger mosquitos, due to climate change, poses a notable public health threat in Europe. A recent study published in The Lancet Planetary Health highlights that due to the mosquitos’ ability to transmit diseases, such as dengue and chikungunya - which were once limited to the tropics - half of the world is now at risk of contracting these illnesses. The immense public health threat of infectious diseases is undeniable and exacerbated by climate change, emphasizing the serious need for proactive disease intervention. At Valneva we are working tirelessly to develop potential solutions to help protect against these kinds of threats. To learn more, read the study here: https://ow.ly/AOmH50W7NUh #travelhealth #infectiousdiseases #mosquitobornediseases #AdvancingVaccinesForBetterLives

We recently celebrated Valneva’s 12th anniversary. For over a decade, our end-to-end approach has allowed us to translate ideas from the lab into real-world solutions. As we mark this milestone, we reaffirm our commitment to developing solutions for infectious diseases with high unmet medical needs. Thanks to our dedicated employees, we know we can continue making a difference in people’s lives. #AdvancingVaccinesForBetterLives